Allergan plc, (NYSE: AGN), a leading global pharmaceutical company, today announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market JUVEDERM ® ULTRA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback